Daniel V. Siev

401 total citations
10 papers, 333 citations indexed

About

Daniel V. Siev is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Daniel V. Siev has authored 10 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Daniel V. Siev's work include Chemical Synthesis and Analysis (8 papers), Click Chemistry and Applications (5 papers) and Peptidase Inhibition and Analysis (5 papers). Daniel V. Siev is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Click Chemistry and Applications (5 papers) and Peptidase Inhibition and Analysis (5 papers). Daniel V. Siev collaborates with scholars based in France and United States. Daniel V. Siev's co-authors include Adnan M.M. Mjalli, Sepehr Sarshar, J. Edward Semple, Xiaodong Cao, Thomas G. Nolan, Edmund J. Moran, Timothy D. Owens, John Reiner, Yu Ge and Susan Y. Tamura and has published in prestigious journals such as Journal of Medicinal Chemistry, Organic Letters and Tetrahedron Letters.

In The Last Decade

Daniel V. Siev

10 papers receiving 281 citations

Peers

Countries citing papers authored by Daniel V. Siev

Since Specialization

Citations

This map shows the geographic impact of Daniel V. Siev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel V. Siev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel V. Siev more than expected).

Fields of papers citing papers by Daniel V. Siev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel V. Siev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel V. Siev. The network helps show where Daniel V. Siev may publish in the future.

Co-authorship network of co-authors of Daniel V. Siev

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel V. Siev. A scholar is included among the top collaborators of Daniel V. Siev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel V. Siev. Daniel V. Siev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	P 1 -単環性アルギニン代替物を有するP 3 -複素環を特徴とする非共有結合性トロンビン阻害剤 2002 ·Bioorganic & Medicinal Chemistry Letters ·John Reiner, Daniel V. Siev, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), J. Edward Semple	20
2	Non-covalent thrombin inhibitors featuring p3-heterocycles with P1-monocyclic arginine surrogates 2002 ·Bioorganic & Medicinal Chemistry Letters ·John Reiner, Daniel V. Siev, (unknown), Jingrong Jean Cui, Jonathan Z. Ho, Komandla Malla Reddy, (unknown), (unknown), (unknown), (unknown), Tony Gibson, (unknown), (unknown), Thomas G. Nolan, J. Edward Semple	25
3	Non-covalent thrombin inhibitors featuring P3-Heterocycles with P1-Bicyclic arginine surrogates 2002 ·Bioorganic & Medicinal Chemistry Letters ·Jingrong Jean Cui, (unknown), John Reiner, Komandla Malla Reddy, Scott J. Kemp, Jonathan Z. Ho, Daniel V. Siev, (unknown), Tony Gibson, (unknown), (unknown), (unknown), (unknown), Thomas G. Nolan, J. Edward Semple	18
4	Novel, potent and selective chimeric FXa inhibitors featuring hydrophobic p1-ketoamide moieties 2000 ·Bioorganic & Medicinal Chemistry Letters ·J. Edward Semple, Odile E. Levy, (unknown), Timothy D. Owens, Daniel V. Siev	15
5	Novel protocol for the solid-phase synthesis of peptidyl and peptidomimetic P1-argininal derivatives 1999 ·Tetrahedron Letters ·Daniel V. Siev, (unknown), J. Edward Semple	7
6	Novel Hydrazino-Carbonyl-Amino- Methylated Polystyrene (HCAM) Resin Methodology for the Synthesis of P₁-Aldehyde Protease Inhibitor Candidates 1999 ·Organic Letters ·Daniel V. Siev, J. Edward Semple	12
7	ChemInform Abstract: Design, Synthesis, and Evolution of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors: P1‐Argininal Derivatives Incorporating P3‐P4 Lactam Sulfonamide Moieties. 1997 ·ChemInform ·J. Edward Semple, David Rowley, Terence K. Brunck, (unknown), (unknown), Timothy D. Owens, Shigeki Tamura, Erick A. Goldman, Daniel V. Siev, Robert Ardecky, (unknown), Yao Ge, (unknown), Thomas G. Nolan, (unknown), A. Tulinsky, R. F. NUTT, William C. Ripka	1
8	Imidazole libraries on solid support 1996 ·Tetrahedron Letters ·Sepehr Sarshar, Daniel V. Siev, Adnan M.M. Mjalli	144
9	Design, Synthesis, and Evolution of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors: P1-Argininal Derivatives Incorporating P3-P4 Lactam Sulfonamide Moieties 1996 ·Journal of Medicinal Chemistry ·J. Edward Semple, David Rowley, Terence K. Brunck, (unknown), (unknown), Timothy D. Owens, Susan Y. Tamura, Erick A. Goldman, Daniel V. Siev, Robert Ardecky, (unknown), Yu Ge, (unknown), Thomas G. Nolan, (unknown), (unknown), Ruth F. Nutt, William C. Ripka	56
10	Synthesis of Nh-acyl-α-aminoamides on rink resin: Inhibitors of the hematopoietic protein tyrosine phosphatase (HePTP) 1995 ·Bioorganic & Medicinal Chemistry Letters ·Xiaodong Cao, Edmund J. Moran, Daniel V. Siev, (unknown), (unknown), Adnan M.M. Mjalli	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact